Gain Therapeutics, Inc.GANXNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 88% recommend buying.

Consensus Rating

Buy

8 analysts·Limited coverage

88%

Rating Distribution

Strong Buy

00%

Buy

788%

Hold

113%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 368% higher.

Bear Case

$7.00

+293%

Consensus

$8.33

+368%

Bull Case

$10.00

+462%

Price Range8 analysts

Low

Consensus

High

$7.00

$10.00

Current Target

Current Price

$1.78

Upside to Target

$6.55

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.71(4 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+350.00%

EPS—

FY2028

Rev+44474.53%

EPS—

FY2029

Rev-48.94%

EPS—

Earnings Surprises

Beat rate:42%(5/12 quarters)

Avg surprise:-2.1%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Dec 19, 2025Roth Capital

Gain Therapeutics price target raised to $10 from $6 at Roth Capital

Target:$10.00

+259.0%from $2.79

Dec 1, 2025H.C. Wainwright

H.C. Wainwright Reiterates Buy Rating on Gain Therapeutics (GANX)

Target:$8.00

+128.6%from $3.50

Oct 7, 2025Maxim Group

Gain Therapeutics price target raised to $7 from $5 at Maxim

Target:$7.00

+255.3%from $1.97

Dec 9, 2022Chardan Capital

Chardan Capital Initiates Coverage On Gain Therapeutics with Buy Rating, Announces Price Target of $4

Target:$4.00

+27.0%from $3.15

Nov 13, 2022BTIG

Gain Therapeutics price target lowered to $10 from $30 at BTIG

Target:$10.00

+211.5%from $3.21

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance